Tag: communicating hydrocephalus
Cerevasc announces presentation of initial eShunt data at ESMINT 2023
Cerevasc has today announced that findings from a clinical study examining the use of its eShunt system to treat communicating hydrocephalus were recently presented...
Cerevasc co-founders honoured with Innovation Award at SVIN 2022
Two neurosurgeons from Tufts Medical Center in Boston, USA have been honoured with the 2022 Innovation Award at this year’s Society of Vascular and...
CereVasc announces US FDA approval for second IDE study of eShunt...
CereVasc announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial...
CereVasc announces publication of first-in-human case report with eShunt system
CereVasc has announced the publication of a case report detailing the first treatment in a study of its eShunt system—an investigational device intended to...
